← Open Payments lookup

BETTY DOBBS: Open Payments

NPI 1558022665 · ACKERMAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$690 in 43 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $690

Food & beverage: $690
CompanyPaymentsAmount
ABBVIE INC.21$192
Otsuka America Pharmaceutical, Inc.6$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$92
Axsome Therapeutics, Inc.3$79
Vanda Pharmaceuticals Inc.3$67
E.R. Squibb & Sons, L.L.C.2$51
Supernus Pharmaceuticals, Inc.2$40
Janssen Pharmaceuticals, Inc1$19

Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, FANAPT, COBENFY, Qelbree, SPRAVATO.

Industry payments across MS — which companies pay providers there.